These results suggest that the T/T genotype of the rs3768490 SNP in GSTM5 may be associated not only with a lower risk of early resistance to ADT, but also with sustained sensitivity to ADT, potentially preventing the development of CRPC in patients with PC. The gene discussed is GSTM5; the disease is pachyonychia congenita.